The rise of GLP-1 receptor agonists such as Mounjaro and Ozempic, combined with the rise of “on-the-go” consumption habits and the “snackification” of meals, has created a shift toward smaller …
BlogIngredient
The rise of GLP-1 receptor agonists such as Mounjaro and Ozempic, combined with the rise of “on-the-go” consumption habits and the “snackification” of meals, has created a shift toward smaller …
42 % of European consumers prioritise “health” or “better-for-you” flavours when choosing food or beverages.* As consumers become more conscious of their food choices, there is a noticeable shift in …
Amid rising health concerns, consumers and public health groups are urging for reduced sodium in food products. Daria Pashkova, Product & Marketing Manager at Ohly, shares her insights. As health …
Fooddrinkinnovations.com © COPYRIGHT 2016